Drug-resistant tuberculosis: emerging treatment options
Meghna Adhvaryu1, Bhasker Vakharia21Department of Biotechnology, SRK Institute of Computer Education and Applied Sciences, 2R&D, Bhuma Research in Ayurvedic and Herbal Medicine, Surat, Gujarat, IndiaAbstract: Multidrug-resistant tuberculosis has emerged worldwide, with an increasing inci...
Guardado en:
Autores principales: | Adhvaryu MR, Vakharia BC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53c2356676b648e4a1619b8ad17caa85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polycythemia Vera (PV): Update on Emerging Treatment Options
por: Benevolo G, et al.
Publicado: (2021) -
Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
por: Helen Humphries, et al.
Publicado: (2021) -
Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series
por: Xing Tan, et al.
Publicado: (2019) -
Modern approaches to pharmacotherapy of tuberculosis infection in children
por: Vasiliy E. Novikov, et al.
Publicado: (2021) -
Melatonergic drugs in development
por: Carocci A, et al.
Publicado: (2014)